Expectations trend
FY2028 · fiscal year ending 2028-03-31 · fmp
LiveRamp Holdings, Inc. (RAMP)
NYSEInformation TechnologySoftware - InfrastructureSnapshot 2026-11-04
$38.50+0.71%
Close 2026-10-30 · 1-day change
NYSEInformation TechnologySoftware - InfrastructureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.49 → 3.49 EPS · FY ending Mar 31, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for RAMP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful merger with Publicis Groupe | The merger with Publicis supports growth and AI capabilities. | Intact | Merger fails or faces major regulatory or competitive blocks | Merger completed 2026-11-02 vs target end 2026 Form 8-K confirms merger completion and NYSE delisting on Nov 2, 2026. Shareholders approved the deal in August. Nov 2, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 3 supplied quarters. Management reported: “Finally, our previously announced transaction with Publicis Groupe remains on track to close before the end of calendar 2026."” “Under the terms of the agreement, Publicis Groupe will acquire all of the outstanding shares of LiveRamp for $38.50 per share in an all-cash transaction for an equity value of $2.5 billion.” |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-03-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
RAMP is a growth and profitability improvement story, with a merger milestone also shaping the thesis. The 1-3 year thesis is intact, supported by recent operating progress, but the business still carries fragile earnings quality and elevated risk.
The valuation evidence points to RAMP as cheap versus peers, and the valuation score recently fell. The expectations gap is negative, while the priced-in assessment says fragility is low and the current setup is justified rather than reflecting a broad stack of risks.
Near term, revenue and operating income have grown, margins have expanded, and management says the Publicis Groupe merger remains on track. These gains support the multi-year case, but a recent earnings miss, a run of misses, and fragile earnings quality make the next results a meaningful risk.
The downside scenario is a guidance cut on the next call, which could reinforce lowered estimates. The favorable case depends on continued revenue and margin progress, the merger closing as planned, and a steadier technology sector; lower interest rates could also help the sector backdrop.
Over the next 1-3 years, RAMP’s thesis rests on converting recent growth and margin gains into reliable execution while completing the merger. The operating picture is improving, but earnings fragility and the risk of weaker guidance remain important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Operating income improves to about $180M in fiscal 2026 | Operating income improved to $15.3M in 2026-Q4. | Intact | Operating income stays below $150M in FY26 | Operating income: $20.163M FY2027-Q1; GAAP. Published target: >= $180M non-GAAP operating income. Annual target cannot be compared with a quarterly or TTM observation. Aug 5, 202620,163,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 3 supplied quarters. Management reported: “Non-GAAP operating income was $50 million, up 41%.” “Non-GAAP operating income was $182 million, up 34%.” Delivery assessment Nov 4, 2026 |
Revenue reaches about $811M in fiscal 2026 | A primary condition in LiveRamp Holdings, Inc.'s published investment case. The stated target is ~$811M. | Intact | Revenue falls below $760M in FY26 | Revenue: $213.986M FY2027-Q1; GAAP. Published target: ~$811M. Annual target cannot be compared with a quarterly or TTM observation. Aug 5, 2026213,986,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.27 → $3.49 · observed estimates
$0.97B → $0.98B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-07-25 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-07-26 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-07-27 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-07-28 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-07-29 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-07-30 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-07-31 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-01 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-02 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-08-03 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-04 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-05 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-08-06 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-07 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-08 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-08-09 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-10 | $3.27 | $972,815,480 | 3 / 4 |
| 2026-08-12 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-13 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-14 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-15 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-16 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-17 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-18 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-19 | $3.83 | $982,553,981 | 2 / 3 |
| 2026-08-20 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-21 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-22 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-23 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-24 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-25 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-26 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-27 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-28 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-29 | $3.76 | $982,587,315 | 2 / 3 |
| 2026-08-30 | $3.94 | $987,850,000 | 2 / 3 |
| 2026-08-31 | $3.94 | $987,850,000 | 2 / 3 |
| 2026-09-01 | $3.94 | $987,850,000 | 2 / 3 |
| 2026-09-02 | $3.94 | $987,850,000 | 2 / 3 |
| 2026-09-03 | $3.94 | $987,850,000 | 2 / 2 |
| 2026-09-04 | $3.94 | $987,850,000 | 2 / 2 |
| 2026-09-05 | $3.94 | $987,850,000 | 2 / 2 |
| 2026-09-06 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-07 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-08 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-09 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-10 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-11 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-12 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-13 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-14 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-15 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-16 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-17 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-18 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-19 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-20 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-21 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-22 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-23 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-24 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-25 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-26 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-27 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-28 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-29 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-09-30 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-10-01 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-10-02 | $3.94 | $987,850,000 | 1 / 1 |
| 2026-10-03 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-04 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-05 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-06 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-07 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-08 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-09 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-10 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-11 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-12 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-13 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-14 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-15 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-16 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-17 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-18 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-19 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-20 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-21 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-22 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-23 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-24 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-25 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-26 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-27 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-28 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-29 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-30 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-10-31 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-11-01 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-11-02 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-11-03 | $3.49 | $975,700,000 | 1 / 1 |
| 2026-11-04 | $3.49 | $975,700,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.